Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18678 | 474 | 21.9 | 68% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ROSUVASTATIN CALCIUM | Author keyword | 8 | 52% | 2% | 11 |
2 | ATORVASTATIN CALCIUM | Author keyword | 6 | 28% | 4% | 18 |
3 | EZETIMIBE GLUCURONIDE | Author keyword | 4 | 75% | 1% | 3 |
4 | N DESMETHYL ROSUVASTATIN | Author keyword | 4 | 75% | 1% | 3 |
5 | SIMVASTATIN ACID | Author keyword | 2 | 29% | 1% | 5 |
6 | LOVASTATIN ACID | Author keyword | 2 | 43% | 1% | 3 |
7 | CONSORZIO INCA | Address | 1 | 38% | 1% | 3 |
8 | FLUVASTATIN SODIUM | Author keyword | 1 | 38% | 1% | 3 |
9 | UDR N OLI 4 | Address | 1 | 38% | 1% | 3 |
10 | CAS 25812 30 0 | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ROSUVASTATIN CALCIUM | 8 | 52% | 2% | 11 | Search ROSUVASTATIN+CALCIUM | Search ROSUVASTATIN+CALCIUM |
2 | ATORVASTATIN CALCIUM | 6 | 28% | 4% | 18 | Search ATORVASTATIN+CALCIUM | Search ATORVASTATIN+CALCIUM |
3 | EZETIMIBE GLUCURONIDE | 4 | 75% | 1% | 3 | Search EZETIMIBE+GLUCURONIDE | Search EZETIMIBE+GLUCURONIDE |
4 | N DESMETHYL ROSUVASTATIN | 4 | 75% | 1% | 3 | Search N+DESMETHYL+ROSUVASTATIN | Search N+DESMETHYL+ROSUVASTATIN |
5 | SIMVASTATIN ACID | 2 | 29% | 1% | 5 | Search SIMVASTATIN+ACID | Search SIMVASTATIN+ACID |
6 | LOVASTATIN ACID | 2 | 43% | 1% | 3 | Search LOVASTATIN+ACID | Search LOVASTATIN+ACID |
7 | FLUVASTATIN SODIUM | 1 | 38% | 1% | 3 | Search FLUVASTATIN+SODIUM | Search FLUVASTATIN+SODIUM |
8 | CAS 25812 30 0 | 1 | 100% | 0% | 2 | Search CAS+25812+30+0 | Search CAS+25812+30+0 |
9 | SIMVASTATIN HYDROXY ACID | 1 | 50% | 0% | 2 | Search SIMVASTATIN+HYDROXY+ACID | Search SIMVASTATIN+HYDROXY+ACID |
10 | DIHEXADECYL HYDROGEN PHOSPHATE | 1 | 30% | 1% | 3 | Search DIHEXADECYL+HYDROGEN+PHOSPHATE | Search DIHEXADECYL+HYDROGEN+PHOSPHATE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HYDROXY ACID | 24 | 57% | 6% | 28 |
2 | BETA HYDROXY ACID | 9 | 64% | 2% | 9 |
3 | COMBINATION DRUG PRODUCTS | 8 | 75% | 1% | 6 |
4 | BULK DRUG | 6 | 26% | 4% | 21 |
5 | POTASSIUM CLAVULANATE | 5 | 45% | 2% | 9 |
6 | PARA HYDROXY ATORVASTATIN | 4 | 75% | 1% | 3 |
7 | ATORVASTATIN CALCIUM | 4 | 36% | 2% | 8 |
8 | MEVINOLINIC ACID | 3 | 38% | 1% | 6 |
9 | UPLC METHOD | 3 | 50% | 1% | 4 |
10 | ACID FORM | 2 | 44% | 1% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Adsorptive stripping voltammetric methods for determination of ezetimibe in tablets | 2011 | 3 | 23 | 91% |
Chromatography-mass spectrometry methods for the quantitation of statins in biological samples | 2007 | 46 | 90 | 31% |
Simvastatin: Review of Updates on Recent Trends in Pharmacokinetics, Pharmacodynamics, Drug-drug Interaction, Impurities and Analytical Methods | 2012 | 3 | 126 | 44% |
Analysis of five HMG-CoA reductase inhibitors-atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies | 2006 | 47 | 80 | 34% |
Analytical methods for the quantitative determination of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in biological samples | 2003 | 56 | 65 | 40% |
Development of electrochemical methods for determination of atorvastatin and analytical application to pharmaceutical products and spiked human plasma | 2004 | 19 | 11 | 27% |
STATINS: CHEMISTRY, ANALYTICAL TECHNIQUES, BIOSYNTHESIS AND PHARMACOKINETICS | 2013 | 0 | 54 | 30% |
Considerations for Metabolite Pharmacokinetic Data in Bioavailability/Bioequivalence Assessments Overview of the recent trends | 2009 | 2 | 36 | 8% |
The use of dihexadecylphosphate in sensing and biosensing | 2015 | 0 | 60 | 7% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CONSORZIO INCA | 1 | 38% | 0.6% | 3 |
2 | UDR N OLI 4 | 1 | 38% | 0.6% | 3 |
3 | CLIN OURO CORDIS | 1 | 100% | 0.4% | 2 |
4 | MITHIBAI ARTS | 1 | 40% | 0.4% | 2 |
5 | ARTE EDERRETAKO FAK | 1 | 50% | 0.2% | 1 |
6 | BIOPHARM PHARMACOKINET UNIT | 1 | 50% | 0.2% | 1 |
7 | JUBLIANT BIOSYS | 1 | 50% | 0.2% | 1 |
8 | PHARMACEUT TECH SERV | 1 | 50% | 0.2% | 1 |
9 | SECAO ANTIBIOT | 1 | 50% | 0.2% | 1 |
10 | SECTOR 59 | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000222114 | HYDROCHLOROTHIAZIDE//AMLODIPINE BESYLATE//LOSARTAN POTASSIUM |
2 | 0.0000190657 | OATP1B1//SLCO1B1//OATP |
3 | 0.0000171132 | OSI 420//OSI 774//CAKI 1 RENAL CELL CARCINOMA |
4 | 0.0000140867 | EZETIMIBE//CHOLESTEROL ABSORPTION INHIBITOR//COLESEVELAM |
5 | 0.0000116333 | PRAVASTATIN//HMG COA REDUCTASE INHIBITOR//COMPACTIN |
6 | 0.0000113046 | MICROEXTRACTION IN PACKED SYRINGE//MICROEXTRACTION BY PACKED SORBENT//POLYSTYRENE SORBENT |
7 | 0.0000092719 | METFORMIN HYDROCHLORIDE//PIOGLITAZONE HYDROCHLORIDE//ROSIGLITAZONE MALEATE |
8 | 0.0000083872 | BIOANALYSIS//BIOANALYT METAB PHARMACOKINET//CASSETTE ANALYSIS |
9 | 0.0000073997 | MONASCUS//MONASCUS PURPUREUS//RED YEAST RICE |
10 | 0.0000067044 | FENOFIBRIC ACID//FENOFIBRATE//FIBRATES |